Thermo Fisher Scientific said this week that it has appointed David Sabatini to its scientific advisory board.
Sabatini is a member of the Whitehead Institute for Biomedical Research, where he studies the basic mechanisms of cell growth. He has several affiliations with the Massachusetts Institute of Technology, serving as senior associate member of the Broad Institute, a member of the David H. Koch Institute for Integrative Cancer Research, and associate professor of biology. He is also an investigator at the Howard Hughes Medical Institute.
Pronota has appointed Carol Greve-Philips as its chief business officer and Els Hublous as chief financial officer.
Greve-Philips comes to Pronota from Genzyme, where she was VP of corporate development. She has also held sales, marketing, and management positions at Amersham, Chemsyn Science Laboratories, Watson Laboratories, and Toxikon.
Hubloux was previously at Capricorn Venture Partners, and has experience in clinical research and development, equity research, and venture capital investing.